P

Praxis Precision Medicines, Inc. Tech Stack

Clinical-stage biotech developing neurological therapies through genetic insights

Biotechnology Research Boston, MA 51–200 employees Public Company

Praxis Precision Medicines is a public clinical-stage biotech translating genetic findings into CNS therapies, with two proprietary platforms (Cerebrum for small molecules, Solidus for antisense oligonucleotides) targeting excitation-inhibition imbalance disorders. Active hiring skews heavily toward healthcare, ops, and manufacturing roles with a director/senior-level focus—reflecting the transition from preclinical work toward Phase III trials and commercial readiness. Current workload centers on quality/GMP compliance, market access strategy, and launch execution for multiple candidates (ulixacaltamide, relutrigine, elsunersen).

Tech Stack 12 technologies

Core StackPython Intune Azure AD Veeva Vault R Veeva QMS macOS Windows Azure Entra ID Microsoft 365 Microsoft Defender for Endpoint Veeva

What Praxis Precision Medicines, Inc. Is Building

◆Challenges

Ensuring gmp compliance
Improving external network efficiency
Commercial launch support
Launching new drug
Avoiding distribution challenges
Building market access infrastructure
Market access strategy
Reimbursement strategy
Managing protocol deviations
Maintaining data integrity

▲Active Projects

Phase-appropriate quality control strategy development
Ulixacaltamide launch
Commercial launch of relutrigine and elsunersen
Global api strategy
Revenue and inventory accounting processes
Stability program strategy
Company-sponsored research strategies
Investigator-initiated studies
Implement risk-based compliance framework
Build medical affairs function

Hiring Activity

Accelerating45 roles · 20 in 30d

Department

Healthcare

8

Ops

6

Engineering

4

Manufacturing

4

Finance

3

Marketing

3

Research

3

Legal

2

Seniority

Senior

16

Director

10

Lead

7

Mid

3

Principal

3

Manager

2

Notable leadership hires: Portfolio Lead, Clinical Quality Director, Quantitative Lead

Company intelligence

Find more companies like Praxis Precision Medicines, Inc. by tech stack, pain points and active projects

Get started free

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company headquartered in Boston developing therapies for rare and more prevalent neurological disorders caused by genetic mutations driving excitation-inhibition imbalance in the brain. The company operates two internal platforms: Cerebrum, a small-molecule discovery engine, and Solidus, an antisense oligonucleotide (ASO) platform. Praxis is currently advancing multiple candidates through clinical trials while preparing for commercial launches. The organization spans 51–200 employees across R&D, clinical, manufacturing, quality, and commercial functions, with active recruitment in healthcare operations, quality assurance, and medical affairs infrastructure.

HeadquartersBoston, MA

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Praxis Precision Medicines working on?

Praxis is advancing ulixacaltamide, relutrigine, and elsunersen toward commercial launch while establishing market access infrastructure, building GMP/quality compliance systems, and developing medical affairs functions. Active projects include phase-appropriate quality control, global API strategy, and reimbursement frameworks.

What tech stack does Praxis Precision Medicines use?

Veeva Vault, Veeva QMS, and Veeva core (regulatory/quality systems); R and Python for data analysis; Microsoft enterprise suite (Azure AD, Azure Entra ID, Intune, Defender, Microsoft 365); and Windows/macOS endpoints.